Intas Pharmaceuticals Limited Busulfan Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Busulfan Export Records India — #1 Exporter, 92 Shipments, $2.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Busulfan

India Pharmaceutical Trade Intelligence

$4.9M33 Suppliers44 CountriesHS 30049049

ExportsIndia → UNITED KINGDOM25.9%India → PERU15.4%

ImportsUNITED STATES → India$25.5K BRAZIL → India$3.3K

#1 Supplier: INTAS PHARMACEUTICALS

Intas Pharmaceuticals Limited — Busulfan Exporter #1 | $2.0M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Busulfan Exporter Profile

Indian Pharmaceutical Exporter · #1 for Busulfan · $2.0M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #1 Indian exporter of Busulfan with $2.0M in export value and 92 verified shipments. Intas Pharmaceuticals Limited holds a 40.4% market share in Busulfan exports across 15 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Busulfan Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Busulfan export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Busulfan?

Country	Value	Shipments	Share
UNITED STATES	$457.7K	12	33.3%
UNITED KINGDOM	$202.7K	10	14.7%
POLAND	$158.6K	6	11.5%
PERU	$130.2K	3

Who Are the Top Buyers of Busulfan from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$179.8K	6
ACCORD UK	UNITED KINGDOM	$111.6K	7
ACCORD HEALTHCARE S.A.C.	PERU	$100.0K	2
MYLAN INSTITUTIONAL INC GSO	UNITED STATES	$100.0K	2
ACCORD HEALTHCARE POLSKA SP Z O O	POLAND	$100.0K	2
TO THE ORDER	UNITED KINGDOM	$93.4K	2
EVERSANA LIFE SCIENCES SERVICES,LL	UNITED STATES	$80.4K	2
ACCORD FARMACEUTICA LTDA	BRAZIL	$66.0K	3
ACCORD HEALTHCARE C/O QESTMED (PTY)	SOUTH AFRICA	$59.9K	2
ACCORD HEALTHCARE THAILAND LTD	THAILAND	$58.6K	2

Intas Pharmaceuticals Limited supplies Busulfan to 35 buyers globally. The largest buyer is EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), followed by ACCORD UK (UNITED KINGDOM) and ACCORD HEALTHCARE S.A.C. (PERU). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Busulfan Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHA.DRU & MEDI, BUSULFAN INJECTION 6MG/M	$114.9K	3
PH.DRU. & MED.: BUFANCORD (BUSULFAN CONC	$100.0K	2
BUSULFAN INJ 6MG/ML 10ML 1X8V MYLAN USA	$100.0K	2
PHARMA DRUGS & MEDI BUSULFAN INJ,6MG/ML,10MLX1VACCORD-PL/RO AS PER DOCUMENT	$100.0K	2
PHARMA DRUG&MED:BUSULFAN INJ,6MG/ML,10ML	$98.6K	8
PHARMA DRUGS & MEDI BUSULFAN INJ,6MG/ML,	$66.6K	8
PHR DRUGS & MEDI ACCORAN BUSULFAN 6MG/ML	$59.9K	2
PHARMA DRUG&MED: BUSSULFANO 60MG/10ML,10ML 1V (AC-BR)EACH ML CONTAINS: BUSULFANPH.EUR. 6MG COLOUR N.A.VLS	$50.0K	1
PHA.DRU & MEDI BUSULFAN INJECTION6MG/ML10ML8V(ACC-US EACH ML CONTAINS BUSULFAN USP 6 MG 1239X1X8VIAL	$50.0K	1
PHARMA DRUGS AND MEDI BUSULFAN INJECTION6MG/ML,10ML8V(ACC-US) BUSULFAN USP 6 MG	$47.5K	1

Intas Pharmaceuticals Limited exports 64 distinct Busulfan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHA.DRU & MEDI, BUSULFAN INJECTION 6MG/M with 3 shipments worth $114.9K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Busulfan Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED ★	$2.0M	92	15	$21.7K
2	EMCURE PHARMACEUTICALS LIMITED	$1.5M	109	9	$14.1K
3	FRESENIUS KABI ONCOLOGY LIMITED	$627.6K	77	7	$8.2K

Intas Pharmaceuticals Limited ranks #1 among 33 Indian Busulfan exporters. Average shipment value of $21.7K compared to the market average of $143.5K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and FRESENIUS KABI ONCOLOGY LIMITED.

Which Indian Ports Ship Busulfan Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	75	20.3%
SAHAR AIR	62	16.8%
DELHI AIR	41	11.1%
DELHI AIR CARGO ACC (INDEL4)	31	8.4%
AHEMDABAD AIR ACC (INAMD4)	26	7.0%
AHEMDABAD AIR	21	5.7%
MUNDRA SEA (INMUN1)	17	4.6%
Ahmedabad Air	13	3.5%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Busulfan Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Busulfan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 108 individual customs records matching Intas Pharmaceuticals Limited exporting Busulfan, covering 64 formulations to 15 countries via 35 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 44+ countries, 109+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Busulfan

Busulfan

Intas Pharmaceuticals Limited — Busulfan Exporter Profile

Intas Pharmaceuticals Limited — Busulfan Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Busulfan?

Who Are the Top Buyers of Busulfan from Intas Pharmaceuticals Limited?

What Is India's Total Busulfan Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Busulfan Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Busulfan Exporters?

What Busulfan Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Busulfan to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Busulfan Exporters?

Which Indian Ports Ship Busulfan Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Busulfan Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Busulfan Export Data from Intas Pharmaceuticals Limited

Busulfan Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source